The strategy in context
Series A+ groups later-stage opportunities, starting with OpenEvidence and Xenter. OpenEvidence works at the intersection of clinical knowledge and AI; Xenter develops medical-device technology and medical intelligence. Their products, structures and requirements are distinct. Xenter remains connected to Cena Ventures within Healthcare as well: both paths lead to the same company opportunity. Category placement is a way to navigate, not an investment rating or an assurance of liquidity.
Public discovery. Protected investment review.
These pages explain the companies and themes using public information. They do not contain confidential offering documents, member data, private valuations or allocations. Join Graphora, complete your profile and review the relevant opportunity through the member platform. Registration does not replace diligence or the requirements for a particular investment.
